ALEXION PHARMACEUTICALS, INC. Insider Trading for May 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALEXION PHARMACEUTICALS, INC. for May 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.77 | 22,720 | 2,743,928 | 7,382,978 | 7.4 M to 7.4 M (-0.31 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.77 | 2,729 | 329,585 | 952,874 | 955.6 K to 952.9 K (-0.29 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.31 | 13,213 | 1,616,054 | 7,405,698 | 7.4 M to 7.4 M (-0.18 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.31 | 1,587 | 194,103 | 955,603 | 957.2 K to 955.6 K (-0.17 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.12 | 15,355 | 1,844,459 | 7,418,911 | 7.4 M to 7.4 M (-0.21 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 120.12 | 1,845 | 221,623 | 957,190 | 959 K to 957.2 K (-0.19 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.37 | 35,796 | 4,380,432 | 7,434,266 | 7.5 M to 7.4 M (-0.48 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 122.37 | 4,300 | 526,200 | 959,035 | 963.3 K to 959 K (-0.45 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 123.06 | 30,766 | 3,786,036 | 7,470,062 | 7.5 M to 7.5 M (-0.41 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 123.06 | 3,696 | 454,826 | 963,335 | 967 K to 963.3 K (-0.38 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 121.37 | 39,732 | 4,822,189 | 7,500,828 | 7.5 M to 7.5 M (-0.53 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 121.37 | 4,772 | 579,168 | 967,031 | 971.8 K to 967 K (-0.49 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 127.06 | 71,819 | 9,125,258 | 7,540,560 | 7.6 M to 7.5 M (-0.94 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 127.06 | 8,627 | 1,096,139 | 971,803 | 980.4 K to 971.8 K (-0.88 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 125.05 | 22,886 | 2,861,901 | 7,612,379 | 7.6 M to 7.6 M (-0.30 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 125.05 | 2,749 | 343,763 | 980,430 | 983.2 K to 980.4 K (-0.28 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 126.25 | 15,541 | 1,962,085 | 7,635,265 | 7.7 M to 7.6 M (-0.20 %) |
May 30 2019 | ALXN | ALEXION PHARMACEUT ... | BAKER BROS. ADVISORS LP | Director | Sell | S | 126.25 | 1,867 | 235,713 | 983,179 | 985 K to 983.2 K (-0.19 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Mollen John T | Director | Grant | A | 0.00 | 2,726 | 0 | 9,233 | 6.5 K to 9.2 K (+41.89 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 740 | 0 | 7,725 | 7 K to 7.7 K (+10.59 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Dunsire Deborah | Director | Grant | A | 0.00 | 2,726 | 0 | 6,985 | 4.3 K to 7 K (+64.01 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,181 | 0 | 33,414 | 31.2 K to 33.4 K (+6.98 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | COUGHLIN CHRISTOPHER J | Director | Grant | A | 0.00 | 2,726 | 0 | 31,233 | 28.5 K to 31.2 K (+9.56 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Rummelt Andreas | Director | Grant | A | 0.00 | 2,726 | 0 | 22,146 | 19.4 K to 22.1 K (+14.04 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Reinsdorf Judith A | Director | Grant | A | 0.00 | 467 | 0 | 7,452 | 7 K to 7.5 K (+6.69 %) |
May 17 2019 | ALXN | ALEXION PHARMACEUT ... | Reinsdorf Judith A | Director | Grant | A | 0.00 | 2,726 | 0 | 6,985 | 4.3 K to 7 K (+64.01 %) |